Matt Callahan
Board Member
pharmaceuticals
Orthocell
Australia
Biography
Mr Callahan is an experienced life sciences executive based in Philadelphia. He is the founding CEO of iCeutica Inc and a co-inventor of some of the technologies that comprise the SoluMatrix Fine Particle Technology™ platform that iCeutica uses to develop new pharmaceuticals. iCeutica has developed two products to date that have received FDA approval, has 1 pending approval and 2 products in late stage development. He has more than 18 years legal, IP and investment management experience and is also a director of Glycan Bioscience LLC and founding CEO of Churchill Pharma.
Research Interest
pharmaceuticals
